It is a healthcare public limited company based in New Delhi, Delhi, India, established in 2010.
2010 | New Delhi, Delhi, India | ActiveVantage Medicines Limited, a active public limited company, was established on 26 February 2010 in New Delhi, Delhi, India. Engaging in medical equipment retail & distribution within the manufacturing sector, it holds CIN: U24100DL2010PLC199565. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Its leadership includes Nitin Gulati (Additional Director), Umesh Sapra (Director), Hemant Shahpuri (Director). Past directors included Pankaj Tandon. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 16-D, H Block, Saket,, New Delhi, Delhi, 110017.
U24100DL2010PLC199565
199565
26 February 2010
₹2.50 M
₹0.50 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Vantage Medicines Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nitin Gulati | Additional Director | 12 May 2011 | Current |
| Umesh Sapra | Director | 26 Feb 2010 | Current |
| Hemant Shahpuri | Director | 26 Feb 2010 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 12 May 2011 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Vantage Medicines Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 24.56% decrease. The company also saw a substantial improvement in profitability, with a 193.65% increase in profit. The company's net worth moved up by a moderate rise of 0.72%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Vantage Medicines had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Vantage Medicines, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Vantage Medicines, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vantage Medicines's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Vantage Medicines Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Vantage Medicines Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.
Nitin Gulati was appointed as a Additional Director was appointed as a Additional Director on 12 May 2011 & has been associated with this company since 14 years 6 months . was recorded as a recent event.
Progress on Umesh Sapra was appointed as a Director was appointed as a Director on 26 Feb 2010 & has been associated with this company since 15 years 9 months . was documented.
Hemant Shahpuri was appointed as a Director was appointed as a Director on 26 Feb 2010 & has been associated with this company since 15 years 9 months . was recorded as a recent event.
The activity Vantage Medicines Limited was registered on 26 Feb 2010 with Roc Delhi & aged 15 years 9 months as per MCA records. was completed.
The CIN of Vantage Medicines Limited is U24100DL2010PLC199565.
Vantage Medicines Limited is headquartered at 16-D, H Block, Saket,, New Delhi, Delhi, 110017.
Vantage Medicines Limited was incorporated on 26 February 2010.
The current directors of Vantage Medicines Limited are
The primary industry of Vantage Medicines Limited is Manufacturing.
Vantage Medicines Limited is unlisted.
The authorized capital of Vantage Medicines Limited is ₹2.50 M, and the paid-up capital is ₹0.50 M.
The compliance status of Vantage Medicines Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX